In today’s briefing:
- CoreWeave (CRWV US): Forecasted Addition to Nasdaq100 Replacing Ansys Post-Acquisition
- Will Gold Stocks Protect You in a Crisis? (Dirk Baur)
- Altcoin Strategic Reserves: Why Are Public Companies Buying Altcoins?
- Boeing Breathes Easy For Now, But AI171 Crash Leaves A Trail Of Uncomfortable Questions!
- Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition!
- OraSure Rebuffs Ron Zwanziger’s Buyout Bid—Will He Try Again?
- FRG: Anchored in Coal, Leveraged to Discovery
- JAKK: 2Q Earnings Preview: Moving Past the Anomaly; Reiterate Buy, $40 PT
- NanoViricides Inc –
- The independent Data Safety Monitoring Board (DSMB) overseeing the AEMD clinical trial has completed its scheduled safety review

CoreWeave (CRWV US): Forecasted Addition to Nasdaq100 Replacing Ansys Post-Acquisition
- The acquisition of Ansys Inc (ANSS US) by Synopsys Inc (SNPS US) has been completed today, 17 July and Ansys is expected to be deleted from Nasdaq100.
- CoreWeave (CRWV US) is forecasted to be added to Nasdaq100 as the replacement because it is the highest ranked eligible non-constituent following its recent listing on 28 March 2025.
- Top addition candidate for the December 2025 annual review is now Kimberly Clark (KMB US) following its listing transfer from NYSE to Nasdaq on 30 May 2025.
Will Gold Stocks Protect You in a Crisis? (Dirk Baur)
- Discussing research on gold and related metals with Dr. Dirk Bauer
- Examining the valuation of gold compared to other asset classes
- Differentiating between gold’s role as a hedge and a safe haven in times of financial turmoil
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.
Altcoin Strategic Reserves: Why Are Public Companies Buying Altcoins?
- Evolving Treasury Landscape: Corporate treasuries face challenges from macroeconomic shifts, including high interest rate volatility, significant monetary expansion leading to inflation, and increasing geopolitical risks impacting cash flows and profitability.
- Bitcoin as a Strategic Asset: Bitcoin has emerged as an alternative asset for these challenges, offering a scarce and increasingly institutionally viable asset for potential long-term value preservation and portfolio diversification, as demonstrated by MicroStrategy’s pioneering strategy.
- The “Financial Engineering” Playbook: MicroStrategy’s approach goes beyond simple asset allocation, employing sophisticated financial engineering (e.g., convertible notes, equity issuances) to create value for shareholders by continuously acquiring more Bitcoin per share.
Boeing Breathes Easy For Now, But AI171 Crash Leaves A Trail Of Uncomfortable Questions!
- The tragic crash of Air India Flight 171, a Boeing 787-8 Dreamliner, on June 12, 2025, initially triggered global alarm over the safety of Boeing’s aircraft, evoking chilling memories of the 737 MAX debacle.
- However, a preliminary report by India’s Aircraft Accident Investigation Bureau (AAIB) appears to shift attention away from mechanical failure and toward pilot actions.
- According to the report, both fuel control switches were inexplicably moved from the “RUN” to the “CUTOFF” position seconds after takeoff—starving both engines of fuel.
Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition!
- Waters Corporation has officially entered a new phase of its growth journey with the $17.5 billion acquisition of Becton Dickinson’s biosciences and diagnostic-solutions business.
- The deal, announced in July 2025, is structured as a merger but effectively represents a strategic divestiture by Becton Dickinson, which has opted to focus more intensively on its core medtech operations.
- Waters, best known for its laboratory instrumentation and software, will issue 39% of its shares to BD shareholders and assume $4 billion in debt.
OraSure Rebuffs Ron Zwanziger’s Buyout Bid—Will He Try Again?
- OraSure Technologies, Inc. outlined its financial results for the first quarter of 2025, revealing a nuanced performance in the face of ongoing industry challenges.
- The quarter saw the company reporting total revenues of $29.9 million, with core revenue—which excludes COVID-19 products and exited businesses—at $29.5 million.
- Although this reflects a slight 2% decrease from the previous year, it marks stability after adjusting for prior business divestitures.
FRG: Anchored in Coal, Leveraged to Discovery
- Forge Resources owns 80% of the fully permitted La Estrella coal project in Colombia.
- Extraction will start as early as January 2026 with a 20,000 ton bulk sample and ramp significantly after that.
- The Alotta copper-gold project in Yukon is an early-stage asset 40km from the world-class Casino deposit.
JAKK: 2Q Earnings Preview: Moving Past the Anomaly; Reiterate Buy, $40 PT
- We are reiterating our Buy rating, projections and $40 price target for JAKKS Pacific with the company announcing 2Q25 (June) results after the close on Thursday.
- We believe China tariffs at 100%+ levels for much of April served to effectively shut down shipments of JAKK product in the beginning of 2Q.
- Further, the company’s Freight On Board (“FOB”) driven business model also served to create a slower return to shipping when the 30% China tariff went into effect on May 12th.
NanoViricides Inc –
- Zacks Small-Cap Research Note for NanoViricides, Inc. (NNVC)
The independent Data Safety Monitoring Board (DSMB) overseeing the AEMD clinical trial has completed its scheduled safety review
- The independent Data Safety Monitoring Board (DSMB) overseeing the AEMD clinical trial has completed its scheduled safety review, recommending that the trial progress to the next patient cohort without modification.
- The company believes overall results thus far support moving the Australia ongoing oncology study forward, launching a similar trial in India and potentially also points to other applications of the Hemopurifier in EV-associated diseases.
- Separately, AEMD, in collaboration with the UCSF Medical Center, has an abstract for poster presentation at the upcoming Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes.
